These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 22331320)
1. Charities lobby EU over access to generic drugs. Gulland A BMJ; 2012 Feb; 344():e1066. PubMed ID: 22331320 [No Abstract] [Full Text] [Related]
2. Brands in peril as Brazil strives to keep AIDS drugs free. Butler D Nature; 2004 Jun; 429(6991):493. PubMed ID: 15175719 [No Abstract] [Full Text] [Related]
3. Canada to change patent law to allow export of cheap drugs. Kondro W Lancet; 2003 Oct; 362(9392):1290. PubMed ID: 14577437 [No Abstract] [Full Text] [Related]
4. TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha. 't Hoen E Chic J Int Law; 2002; 3(1):27-46. PubMed ID: 15709298 [No Abstract] [Full Text] [Related]
5. Brazil and India file complaint against EU over seizure of generic drugs. Zarocostas J BMJ; 2010 May; 340():c2672. PubMed ID: 20483945 [No Abstract] [Full Text] [Related]
6. Proposed EU-India free trade agreement could impede manufacture of generic HIV drugs. Chu SK HIV AIDS Policy Law Rev; 2011 Apr; 15(2):22-3. PubMed ID: 21688702 [TBL] [Abstract][Full Text] [Related]
7. [The patent legislation in India fails the HIV/AIDS work]. Holen Ø Tidsskr Nor Laegeforen; 2005 Oct; 125(19):2666-7. PubMed ID: 16215618 [No Abstract] [Full Text] [Related]
8. Indian pressure group challenges company's right to patent AIDS drug. Mudur G BMJ; 2006 May; 332(7551):1176. PubMed ID: 16709987 [No Abstract] [Full Text] [Related]
9. World Trade Organization wrestles with access to cheap drugs solution. Loff B Lancet; 2002 Nov; 360(9346):1670. PubMed ID: 12457799 [No Abstract] [Full Text] [Related]
10. Indian generic drug production. Benefits of EU-India free trade agreement. Ager B BMJ; 2011 Apr; 342():d2439. PubMed ID: 21502277 [No Abstract] [Full Text] [Related]
11. Trade systems in less-developed countries. Kamal Smith M; 't Hoen E Lancet; 2001 May; 357(9268):1624. PubMed ID: 11386324 [No Abstract] [Full Text] [Related]
12. Intellectual property law in Israel, and US and European objections: Market exclusivity vs. data exclusivity. Morag-Sela T; Cohn I; Kowalski TJ; Jarecki-Black J; Clyde-Watson Z Nat Biotechnol; 2004 Dec; 22(12):1591-2. PubMed ID: 15583670 [No Abstract] [Full Text] [Related]
13. Mixed WTO ruling on generic drug development. Elliott R Can HIV AIDS Policy Law Newsl; 2000; 5(2-3):38-42, 40-4. PubMed ID: 11833195 [TBL] [Abstract][Full Text] [Related]
14. Essential AIDS medications in India. Thomas J Issues Med Ethics; 2000; 8(2):62. PubMed ID: 16323350 [No Abstract] [Full Text] [Related]
15. [What drug companies actually do]. Tonby K Tidsskr Nor Laegeforen; 2007 Jun; 127(13):1806. PubMed ID: 17599137 [No Abstract] [Full Text] [Related]
16. Indian biogenerics industry emerges. Jayaraman KS Nat Biotechnol; 2003 Oct; 21(10):1115-6. PubMed ID: 14520378 [No Abstract] [Full Text] [Related]
17. Tripping over patents: AIDS, access to treatment and the manufacturing of scarcity. Berger JM Conn J Int Law; 2002; 17(2):157-248. PubMed ID: 12688292 [No Abstract] [Full Text] [Related]
18. The production of generic drugs in India. Love J BMJ; 2011 Mar; 342():d1694. PubMed ID: 21427048 [No Abstract] [Full Text] [Related]
19. Global trade and access to medicines: AIDS treatments in Thailand. Wilson D; Cawthorne P; Ford N; Aongsonwang S Lancet; 1999 Nov; 354(9193):1893-5. PubMed ID: 10584741 [No Abstract] [Full Text] [Related]
20. Canada ordered to implement WTO ruling against "stockpiling" of generic drugs. Elliott R Can HIV AIDS Policy Law Rev; 2000; 5(4):27. PubMed ID: 11833161 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]